ŌURA, a wearable device company, has secured $200 million in Series D funding to expand its product offerings, the company announced last week.
ŌURA, which was founded in Finland in 2013, offers a wearable smart…
Continue Reading
What You Should Know:
– Dexcom, the global leader in continuous glucose monitoring (CGM), has achieved another groundbreaking milestone by launching the first generative AI (GenAI) platform in glucose biosensing technology, Stelo.
– The Stelo platform…
Continue Reading
What You Should Know:
– Tandem Diabetes Care, an insulin pump manufacturer, has announced expanded compatibility for its t:slim X2™ insulin pump in Canada.
– In-warranty users can now integrate their pumps with both the Dexcom…
Continue Reading
Introduction
Dexcom, a leader in continuous glucose monitoring (CGM) technology, has revolutionized diabetes management and ventured into broader health and wellness applications. With over 25 years of innovation, the company is forging partnerships and expanding…
Glucose-monitoring specialist Dexcom made several announcements this year, including receiving FDA clearance for its over-the-counter continuous glucose monitoring (CGM) solution Stelo, G7’s expanded capabilities to connect directly to the Apple Watch and, most recently,…
Continue Reading
What You Should Know:
– DexCom, the global leader in continuous glucose monitoring (CGM), and ŌURA, the maker of the leading smart ring, have announced a strategic partnership to help millions of people improve their…
Continue Reading
Copyright: Julien Behal
What You Should Know:
– Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland.
– Abbott’s FreeStyle Libre portfolio is…
Continue Reading
What You Should Know:
– Abbott announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and MRIs.
–…
Continue Reading
What You Should Know:
– Ascensia Diabetes Care has announced the U.S. launch of the Eversense® 365 continuous glucose monitoring (CGM) system, an advancement in diabetes management.
– Developed by Senseonics Holdings, Inc., Eversense 365 is…
Continue Reading
An interdisciplinary team of researchers from various Chinese universities have developed a miniature-sized continuous glucose monitoring system that works as effectively as market-leading systems.WHAT IT’S ABOUT
The CGM sensor is made of an organic electrochemical…
